← Back
$ATNF All transactions

180 Life Sciences Corp.

A

$ Value

$0

Shares

255,000

Price

$0

Filed

Jun 30

Insider

Name

Smith Ryan Lewis

Title

CIK

0001619129

Roles

Director

Transaction Details

Transaction Date

2025-06-17

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

255,000

Footnotes

Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan (the "Equity Plan"). | Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. | The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained.

Filing Info

Accession No.

0001213900-25-059797

Form Type

4/A

Issuer CIK

0001690080

Smith Ryan Lewis's History

Date Ticker Type Value
2026-04-02 FRMM A $0
2026-03-31 USEG $13K
2026-03-19 USEG F $20K
2026-03-04 USEG A $0
2026-02-18 ETHZ J $0
2026-02-13 USEG F $39K
2026-01-05 USEG F $21K
2025-12-01 ETHZ G $0
2025-12-01 ETHZ G $0
2025-11-14 ETHZ G $0

Other Insiders at ATNF (90d)

Insider Bought Sold Last
New Jason Griffin 2026-04-02
Rudisill McAndrew
Chief Executive Officer
2026-04-02
Smith Ryan Lewis 2026-04-02
Dalton Angela 2026-04-02
SUCKLING ANDREW P 2026-04-02
Heter Crystal Jane 2026-04-02
Saunders John Tazewell
Chief Financial Officer
2026-04-02
Edwards Michael A 2026-04-02